Yukawa N - Search Results

1

Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.

Tamagawa H, Oshima T, Numata M, Yamamoto N, Shiozawa M, Morinaga S, Nakamura Y, Yoshihara M, Sakuma Y, Kameda Y, Akaike M, Yukawa N, Rino Y, Masuda M, Miyagi Y. Tamagawa H, et al. Among authors: yukawa n. Eur J Surg Oncol. 2013 Jun;39(6):655-61. doi: 10.1016/j.ejso.2013.02.023. Epub 2013 Mar 21. Eur J Surg Oncol. 2013. PMID: 23523318

2

[Intraoperative radiation therapy (IORT) for locally unresectable pancreatic cancer].

Miyamatsu A, Morinaga S, Yukawa N, Akaike M, Sugimasa Y, Takemiya S. Miyamatsu A, et al. Among authors: yukawa n. Gan To Kagaku Ryoho. 1999 Oct;26(12):1846-8. Gan To Kagaku Ryoho. 1999. PMID: 10560409 Japanese.

3

[Therapeutic strategy for hepatic metastasis of primary colon cancer].

Yukawa N, Akaike M, Sugimasa Y, Takemiya S, Motohashi H. Yukawa N, et al. Gan To Kagaku Ryoho. 2001 Oct;28(11):1565-8. Gan To Kagaku Ryoho. 2001. PMID: 11707981 Japanese.

4

Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Noguchi Y, Takanashi Y. Yukawa N, et al. Br J Surg. 2001 Dec;88(12):1596-601. doi: 10.1046/j.0007-1323.2001.01930.x. Br J Surg. 2001. PMID: 11736971

5

Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Imada T, Noguchi Y. Yukawa N, et al. Anticancer Res. 2004 May-Jun;24(3b):2101-5. Anticancer Res. 2004. PMID: 15274408 Free article.

6

A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.

Rino Y, Takanashi Y, Yukawa N, Saeki H, Wada H, Kanari M, Yamada R, Satoh T, Yamamoto N, Imada T. Rino Y, et al. Among authors: yukawa n. Anticancer Res. 2006 Mar-Apr;26(2B):1455-62. Anticancer Res. 2006. PMID: 16619558 Free article. Clinical Trial.

7

Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.

Rino Y, Tarao K, Morinaga S, Ohkawa S, Miyakawa K, Hirokawa S, Masaki T, Tarao N, Yukawa N, Saeki H, Takanashi Y, Imada T. Rino Y, et al. Among authors: yukawa n. Anticancer Res. 2006 May-Jun;26(3B):2221-6. Anticancer Res. 2006. PMID: 16821591 Free article.

8

Technique and assessment of sentinel lymph node biopsy usefulness in laparoscopy-assisted distal gastrectomy.

Rino Y, Takanashi Y, Harada H, Ashida A, Saeki H, Yukawa N, Kanari M, Satoh T, Yamamoto N, Yamada R, Imada T. Rino Y, et al. Among authors: yukawa n. Surg Endosc. 2006 Dec;20(12):1887-91. doi: 10.1007/s00464-006-0043-2. Surg Endosc. 2006. PMID: 17024528

9

Laparoscopy-assisted distal gastrectomy with 3-cm laparotomy, left hepatic lobe compression technique, and selection of automatic anastomosis device.

Rino Y, Ashida A, Harada H, Kawamoto M, Inagaki D, Yukawa N, Saeki H, Kanari M, Yamada T, Masuda M, Ohshima T, Yamada R, Imada T. Rino Y, et al. Among authors: yukawa n. Hepatogastroenterology. 2007 Jan-Feb;54(73):4-9. Hepatogastroenterology. 2007. PMID: 17419220

10

Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.

Saeki H, Yanoma S, Takemiya S, Sugimasa Y, Akaike M, Yukawa N, Rino Y, Imada T. Saeki H, et al. Among authors: yukawa n. Oncol Rep. 2007 Aug;18(2):433-9. Oncol Rep. 2007. PMID: 17611667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters